title: [Interstitial pneumonitis].
abstract: The risk management of interstitial pneumonitis in cancer chemotherapy not only involves an adverse event by an anticancer drug, but there are four steps with the incidence of interstitial pneumonitis: 1 ) the time before chemotherapy treatment, selection of chemotherapy regimens and patients, 2 ) the time chemotherapy treatment is performed, 3 ) the time during following-up, 4 ) the time when interstitial pneumonitis occurs. It is necessary to decrease the risk of interstitial pneumonitis by several steps, cooperating with an entire medical staff.
authors.affiliation: Dept. of Thoracic Oncology, National Kyushu Cancer Center, Japan.
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Hirai
authors.forename: Gouji
authors.initials: G
authors.lastname: Toyokawa
authors.forename: Taro
authors.initials: T
authors.lastname: Ohba
authors.forename: Hiromoto
authors.initials: H
authors.lastname: Kitajima
authors.forename: Masafumi
authors.initials: M
authors.lastname: Yamaguchi
authors.forename: Riichiroh
authors.initials: R
authors.lastname: Maruyama
authors.forename: Motoharu
authors.initials: M
authors.lastname: Hamatake
authors.forename: Takashi
authors.initials: T
authors.lastname: Seto
authors.forename: Kenji
authors.initials: K
authors.lastname: Sugio
authors.forename: Yukito
authors.initials: Y
authors.lastname: Ichinose
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D007258:Informed Consent; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy*; D009369:Neoplasms / Q000188:drug therapy; D012308:Risk Management
chemical_list: D000970:Antineoplastic Agents